Foundry Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
227
-50
-18% -$51.1K 0.12% 56
2026
Q1
$255K Buy
277
+82
+42% +$83.1K 0.13% 54
2025
Q4
$210K Buy
+195
New +$186K 0.1% 61

Other funds holding LLY

Foundry Financial Group's LLY Position: Q2 2026 in Review

Foundry Financial Group reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $51.1K and leaving 227 shares worth $272K. The position accounts for 0.12% of the portfolio, ranked #56.

Foundry Financial Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Foundry Financial Group held 227 shares of Eli Lilly worth $272K as of Q2 2026.
  • Foundry Financial Group sold 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.12% of Foundry Financial Group's portfolio in Q2 2026, its #56 holding.
  • Foundry Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Foundry Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.